Are We Misdiagnosing ADHD in Patients With OCD?
July 6th 2015The rate of co-occurrence of ADHD and OCD has been reported to be as high as 60%. A question persists, however, on whether ADHD-OCD comorbidity is a true entity or whether symptoms attributed to one may be facets of a phenotype of the other.
Setting the Stage for Opioid Addiction Treatment
June 8th 2015Opioid-dependent patients presenting to an emergency department for other medical reasons are more likely to pursue addiction treatment if a specific therapy is initiated during their emergency care stay. What therapy are we talking about?
The National Ataxia Foundation Champions Research, Education, and Support Services
November 1st 2007Ataxia is a relatively rare, genetic neuromuscular disorder, affecting about 150,000 persons in the United States. It is one of those disorders for which knowledge is growing but is slow to get to the practicing clinician. Hence, many persons with ataxia go for years with no diagnosis or a misdiagnosis. Alternately, because ataxia is a progressive disorder without a cure, many patients are given a stark diagnosis and sent home to cope with the disorder on their own.
Potassium Channel Opener May Become Resource for Treating Resistant Epilepsy
November 1st 2007In the early 1990s, researchers began looking at potassium channel openers for seizure control. Over the past 10 years, in vitro research and animal studies demonstrated that potassium channel openers could control seizure activity in a dose-dependent way. Clinical trials are now confirming these findings.
Nonmotor PD Symptoms Are Many and Deserve Attention
August 1st 2007Nonmotor symptoms of Parkinson disease [PD] are diverse and include sleep disorders, depression, and pain," reported Carlo Colosimo, MD, assistant professor of neurology at La Sapienza University in Rome. He noted that a screening tool is needed.
Mind Over Matter: BCIs on the Fast Track for the New Age
July 1st 2007In past discussions on brain-computer interfaces (BCIs), parallels were drawn between emerging applications and the idea of the "bionic man." However, a presentation by John P. Donoghue, PhD, during a "Hot Topics" plenary session on May 2 at the 59th Annual Meeting of American Academy of Neurology in Boston suggests that current neural interface technology is much more about the marvels of the human neuron and will than about machinery.
AChE Inhibitor May Finesse Baroreflex Problems Common to Ganglionopathies
July 1st 2007One of the most common symptoms of autonomic neuropathy is orthostatic hypotension (OH). It is treatable; however, the only FDA-approved therapeutic agent for OH, midodrine, causes supine hypertension. This hypertension occurs to a greater degree and for a longer period than bouts of OH, explained Philip A. Low, MBBS, MD, during a plenary session at the 59th Annual Meeting of the American Academy of Neurology (AAN), held in Boston, April 28 to May 5.